AQR Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.05M Sell
2025
Q1
$861K Buy
2022
Q3
Sell
2022
Q2
$517K Sell
2022
Q1
$570K Buy
2021
Q4
$513K Buy
2021
Q3
$432K Buy
2021
Q2
$356K Buy